VACCINES SAFETY: EFFECT OF SUPERVISION AND SMS ON IMPROVING THE REPORTING RATE OF ADVERSE EVENTS FOLLOWING IMMUNIZATION.

Trial Profile

VACCINES SAFETY: EFFECT OF SUPERVISION AND SMS ON IMPROVING THE REPORTING RATE OF ADVERSE EVENTS FOLLOWING IMMUNIZATION.

Completed
Phase of Trial: Phase I

Latest Information Update: 14 Sep 2016

At a glance

  • Drugs Meningococcal vaccine group A conjugate (Primary)
  • Indications Meningococcal infections
  • Focus Adverse reactions
  • Acronyms 4ISAFETY
  • Most Recent Events

    • 19 May 2016 Status changed from not yet recruiting to completed.
    • 13 May 2016 Results (n=1124) assessing the incidence and types of adverse events following immunization (AEFIs) published in the Pharmacoepidemiology and Drug Safety
    • 14 Feb 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top